CN103169556B - 一种可显影的完全可降解支架及其制备方法 - Google Patents
一种可显影的完全可降解支架及其制备方法 Download PDFInfo
- Publication number
- CN103169556B CN103169556B CN201310056527.1A CN201310056527A CN103169556B CN 103169556 B CN103169556 B CN 103169556B CN 201310056527 A CN201310056527 A CN 201310056527A CN 103169556 B CN103169556 B CN 103169556B
- Authority
- CN
- China
- Prior art keywords
- wholly
- bar
- developing
- hole
- degradable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000011241 protective layer Substances 0.000 claims abstract description 63
- 239000010410 layer Substances 0.000 claims abstract description 43
- 229920001610 polycaprolactone Polymers 0.000 claims abstract description 40
- 229920001432 poly(L-lactide) Polymers 0.000 claims abstract description 30
- 239000004632 polycaprolactone Substances 0.000 claims abstract description 22
- 239000002872 contrast media Substances 0.000 claims abstract description 20
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims abstract description 15
- 229960001025 iohexol Drugs 0.000 claims abstract description 9
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 claims abstract description 9
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 claims abstract description 8
- AMDBBAQNWSUWGN-UHFFFAOYSA-N Ioversol Chemical compound OCCN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I AMDBBAQNWSUWGN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960002603 iopromide Drugs 0.000 claims abstract description 7
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960004537 ioversol Drugs 0.000 claims abstract description 7
- 230000005540 biological transmission Effects 0.000 claims description 15
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 9
- MIKKOBKEXMRYFQ-WZTVWXICSA-N meglumine amidotrizoate Chemical compound C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I MIKKOBKEXMRYFQ-WZTVWXICSA-N 0.000 claims description 6
- 239000000463 material Substances 0.000 abstract description 38
- 239000003550 marker Substances 0.000 abstract description 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 229960005423 diatrizoate Drugs 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 26
- 238000000034 method Methods 0.000 description 21
- 238000011161 development Methods 0.000 description 20
- 238000001035 drying Methods 0.000 description 16
- 229920000642 polymer Polymers 0.000 description 15
- 229910000831 Steel Inorganic materials 0.000 description 13
- 239000010959 steel Substances 0.000 description 13
- 238000001291 vacuum drying Methods 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 11
- 238000002513 implantation Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 8
- 229920006237 degradable polymer Polymers 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000004080 punching Methods 0.000 description 4
- 210000001215 vagina Anatomy 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002697 interventional radiology Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- CMXPERZAMAQXSF-UHFFFAOYSA-M sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate;1,8-dihydroxyanthracene-9,10-dione Chemical compound [Na+].O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O.CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC CMXPERZAMAQXSF-UHFFFAOYSA-M 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310056527.1A CN103169556B (zh) | 2013-02-22 | 2013-02-22 | 一种可显影的完全可降解支架及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310056527.1A CN103169556B (zh) | 2013-02-22 | 2013-02-22 | 一种可显影的完全可降解支架及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103169556A CN103169556A (zh) | 2013-06-26 |
CN103169556B true CN103169556B (zh) | 2015-04-15 |
Family
ID=48630057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310056527.1A Active CN103169556B (zh) | 2013-02-22 | 2013-02-22 | 一种可显影的完全可降解支架及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103169556B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104056307B (zh) * | 2014-05-29 | 2016-05-11 | 深圳市信立泰生物医疗工程有限公司 | 一种显影可降解聚合物支架及其制备方法 |
CN106333773B (zh) * | 2015-07-07 | 2018-05-08 | 先健科技(深圳)有限公司 | 血管支架 |
US20170105856A1 (en) * | 2015-10-16 | 2017-04-20 | Abbott Cardiovascular Systems Inc. | Non-circular radiopaque markers and methods for attaching a marker to a scaffold |
CN105902331A (zh) * | 2016-04-08 | 2016-08-31 | 南京永明医疗器械有限公司 | 一种血管支架及其制备方法 |
CN106178121B (zh) * | 2016-09-09 | 2022-06-03 | 中国医科大学附属第一医院 | 一种x线下显影血管替代物及制备方法 |
CN109091275B (zh) * | 2018-08-24 | 2024-01-30 | 四川大学 | 生物可降解支架 |
CN109550085B (zh) * | 2018-11-20 | 2021-09-14 | 山东瑞安泰医疗技术有限公司 | 一种治疗血管腔内损伤出血的支架套及其制备方法 |
CN113855352B (zh) * | 2020-06-30 | 2023-01-03 | 微创神通医疗科技(上海)有限公司 | 显影结构、支架及取栓系统 |
CN113855353B (zh) * | 2020-06-30 | 2023-01-03 | 微创神通医疗科技(上海)有限公司 | 显影结构、支架及取栓系统 |
CN113648113B (zh) * | 2021-08-18 | 2024-02-02 | 南京友德邦医疗科技有限公司 | 一种可降解支架 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN202184823U (zh) * | 2011-05-20 | 2012-04-11 | 浙江康正医疗器械有限公司 | 微孔冠脉可吸收支架 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7208010B2 (en) * | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
EP2323708A4 (en) * | 2008-08-07 | 2015-11-18 | Exogenesis Corp | DRUG DELIVERY SYSTEM AND METHOD FOR MANUFACTURING THE SAME |
-
2013
- 2013-02-22 CN CN201310056527.1A patent/CN103169556B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN202184823U (zh) * | 2011-05-20 | 2012-04-11 | 浙江康正医疗器械有限公司 | 微孔冠脉可吸收支架 |
Also Published As
Publication number | Publication date |
---|---|
CN103169556A (zh) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169556B (zh) | 一种可显影的完全可降解支架及其制备方法 | |
US7261734B2 (en) | Resorption-controllable medical implants | |
AU2014265460B2 (en) | Bioabsorbable biomedical implants | |
JP2009542352A (ja) | 放射線不透過性マーカーを備えたステント及びその製造方法 | |
CN104287876A (zh) | 网格 | |
CN102151185A (zh) | 一种具有多层涂层的生物可降解支架 | |
CN102440856A (zh) | 一种x射线下可见的生物可降解支架及其制备方法 | |
CN202184823U (zh) | 微孔冠脉可吸收支架 | |
CN104644295B (zh) | 一种可吸收管腔支架及其制备方法 | |
JP2022079625A (ja) | 生分解が管理された医療デバイス | |
CN110051889B (zh) | 一种聚乳酸纤维增强血管支架及其制备方法 | |
CN103110985A (zh) | 一种有多种药物的生物可降解支架 | |
Mahmud et al. | 3D‐printed polymer nanocomposites with carbon quantum dots for enhanced properties and in situ monitoring of cardiovascular stents | |
CN102727331A (zh) | 生物可降解镁合金胆管溶石编织支架及制备方法 | |
CN102961204A (zh) | 可降解婴幼儿镁合金食管支架 | |
CN204618497U (zh) | 一种生物可降解支架 | |
Pavcnik et al. | Double BioDisk: a new bioprosthetic device for transcatheter closure of atrial septal defects-a feasibility study in adult sheep | |
Lin et al. | Poly-l-lactide/sodium alginate/chitosan microsphere hybrid scaffolds made with braiding manufacture and adhesion technique: Solution to the incongruence between porosity and compressive strength | |
Lee et al. | Promoting vascular healing using nanofibrous ticagrelor-eluting stents | |
CN102371006A (zh) | 一种生物可降解支架 | |
CN112274204B (zh) | 医用弹簧圈 | |
CN109602523B (zh) | 一种可回收的药物支架 | |
CN202960837U (zh) | 一种可被人体吸收的婴幼儿镁合金食管支架 | |
CN102727943A (zh) | 生物可降解聚合物编织的溶石胆管支架及制备方法 | |
CN111067679A (zh) | 一种具有高支撑强度的颅内可降解聚酯支架 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 518118 Guangdong province Shenzhen Pingshan New District Industrial Zone planning five road No. 1 Patentee after: SHENZHEN SALUBRIS BIOMEDICAL ENGINEERING Co.,Ltd. Address before: 518102 Guangdong Province, Shenzhen city Xixiang Street No 115 District 1 factories Patentee before: SHENZHEN SALUBRIS BIOMEDICAL ENGINEERING Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: 518118, No. five, No. 1, great industrial zone, Ping Shan, Guangdong, Shenzhen Patentee after: SHENZHEN SALUBRIS BIOMEDICAL ENGINEERING Co.,Ltd. Address before: 518118 Guangdong province Shenzhen Pingshan New District Industrial Zone planning five road No. 1 Patentee before: SHENZHEN SALUBRIS BIOMEDICAL ENGINEERING Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 518118, No. five, No. 1, great industrial zone, Ping Shan, Guangdong, Shenzhen Patentee after: SHENZHEN SALUBRIS BIOMEDICAL ENGINEERING Co.,Ltd. Address before: 518118 Guangdong province Shenzhen Pingshan New District Industrial Zone planning five road No. 1 Patentee before: SHENZHEN SALUBRIS BIOMEDICAL ENGINEERING Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 518118 No.1, Guihua 5th Road, Pingshan District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Xinlitai Medical Equipment Co.,Ltd. Address before: 518118 No.1, Guihua 5th Road, Pingshan District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN SALUBRIS BIOMEDICAL ENGINEERING Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |